Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease

BACKGROUND: Current studies suggest mitochondrial dysfunction is a major contributor to impaired physical performance and exercise intolerance in chronic kidney disease (CKD). We conducted a clinical trial of coenzyme Q10 (CoQ10) and nicotinamide riboside (NR) to determine their impact on exercise t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Armin, Begue, Gwenaelle, Valencia, Ana P., Norman, Jennifer E., Lidgard, Benjamin, Bennett, Brian J., Van Doren, Matthew P., Marcinek, David J., Fan, Sili, Prince, David K., Gamboa, Jorge, Himmelfarb, Jonathan, de Boer, Ian H., Kestenbaum, Bryan R., Roshanravan, Baback
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393227/
https://www.ncbi.nlm.nih.gov/pubmed/37159264
http://dx.doi.org/10.1172/jci.insight.167274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393227/
https://www.ncbi.nlm.nih.gov/pubmed/37159264
http://dx.doi.org/10.1172/jci.insight.167274

Ejemplares similares